Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Coronary artery disease |
📓
Compositional change of gut microbiome and osteocalcin expressing endothelial progenitor cells in patients with coronary artery disease. PloS one (PLoS One ) Vol: 16 Issue 3 Pages: e0249187 Pub: 2021 Epub: 2021 Mar 25 Authors Toya T , Ozcan I , Corban MT , Sara JD , Marietta EV , Ahmad A , Horwath IE , Loeffler DL , Murray JA , Lerman LO , Lerman A , Html Article Publication |
| Coronary artery disease |
📓
Coronary artery disease is associated with an altered gut microbiome composition. PloS one (PLoS One ) Vol: 15 Issue 1 Pages: e0227147 Pub: 2020 Epub: 2020 Jan 29 Authors Toya T , Corban MT , Marrietta E , Horwath IE , Lerman LO , Murray JA , Lerman A , Html Article Publication |
| Coronary artery disease |
📓
The Microbial and Metabolic Signatures of Patients with Stable Coronary Artery Disease. Microbiology spectrum (Microbiol Spectr ) Vol: 10 Issue 6 Pages: e0246722 Pub: 2022 Dec 21 Epub: 2022 Nov 10 Authors Zhong J , Wu D , Zeng Y , Wu G , Zheng N , Huang W , Li Y , Tao X , Zhu W , Sheng L , Shen X , Zhang W , Zhu R , Li H , Html Article Publication |
| Coronary artery disease |
📓
Gut microbiota composition reflects disease progression, severity and outcome, and dysfunctional immune responses in patients with hypertensive intracerebral hemorrhage. Frontiers in immunology (Front Immunol ) Vol: 13 Issue Pages: 869846 Pub: 2022 Epub: 2022 Oct 14 Authors Luo J , Chen Y , Tang G , Li Z , Yang X , Shang X , Huang T , Huang G , Wang L , Han Y , Zhou Y , Wang C , Wu B , Guo Q , Gong B , Li M , Wang R , Yang J , Cui W , Zhong J , Zhong LL , Guo J , Html Article Publication |
| Coronary artery disease |
📓
Gut Lactobacillus Level Is a Predictive Marker for Coronary Atherosclerotic Lesions Progress and Prognosis in Patients With Acute Coronary Syndrome. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 11 Issue Pages: 687827 Pub: 2021 Epub: 2021 Sep 7 Authors Gao J , Wang J , Zhao LL , Yao TT , Chen Y , Ma J , Zhang X , Wang JX , Wang Y , Cui Z , Liu Y , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
